The Coronary Artery Inflammation Controversy
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"The Coronary Artery Inflammation Controversy" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Cardiovascular Business, diagnosticimaging.com, dicardiology.com and Forbes. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 70d ago.
Quick answers
Why is "The Coronary Artery Inflammation Controversy" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- ESC 2026: Biomarker indicates coronary inflammation from non-contrast CT Yahoo · 70d ago
- ORFAN-MAESTRIA: AI Predicts Cardioembolic Stroke, Atrial Fibrillation from CT Scans HCPLive · 70d ago
- AI tech uses cardiac CT scans to evaluate inflammation, predict stroke risk Cardiovascular Business · 70d ago
- What CCTA-Based AI Detection of Coronary Inflammation May Reveal About Patients with No Traditional CV Risk Factors diagnosticimaging.com · 70d ago
- New Data Validates FAI-Score Biomarker, Highlights Potential Non-Contrast Cardiac CT Opportunity dicardiology.com · 70d ago
- ZEUS And Lp(a)HORIZON: Biomarkers Vs. Cardiovascular Outcomes Forbes · 70d ago
- The Coronary Artery Inflammation Controversy Ground Truths | Eric Topol · 70d ago
Topics
Related trends
The Offshore Wind Industry Gave Him the Well-Paying Work He Needed. Then Trump Gutted It.
Federal actions and policy shifts under Trump have severely impacted the United States offshore wind sector, threatening jobs and investments.
The Fed chief said AI would tame inflation. His colleagues disagree.
Federal Reserve officials are publicly divided over whether artificial intelligence infrastructure is driving or taming inflation.
Here's Why The Dire Wolf Really Wasn't Brought Back From Extinction, Scientists Argue
Scientists push back on claims that dire wolves have been resurrected, arguing the animals are genetically modified gray wolves, not true de-extinction.
The Archbishop of San Francisco on Staying Human in the AI Age
Pope Leo XIV's new AI encyclical sparks global Catholic dialogue as tech workers and theologians debate human dignity in the algorithmic age.
Russell Brand and David Walliams joked about gay 'smokescreen' tactic that 'works well' years before scandals
A 2006 TV clip shows Russell Brand and David Walliams joking that pretending to be gay works as a 'wonderful smokescreen,' resurfacing after Brand's rape conviction and sexual misconduct allegations against Walliams.
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial
The ZEUS clinical trial found that the anti-inflammatory drug ziltivekimab did not reduce major cardiovascular events in high-risk patients.